Leu/Val SNP polymorphism of CYP1B1 and risk of uterine leiomyoma in a Black population
- 127 Downloads
Uterine leiomyoma (UL) is the most commonly occurring benign tumor that affects women of reproductive ages. Studies strongly suggest that ULs are hormonally dependent and that genes acting in estrogen metabolism might be involved in their development. The focus of this case–control study was to determine whether the Leucine432Valine single-nucleotide polymorphism (SNP) in the gene encoding cytochrome P450 1B1 (CYP1B1) was associated with an increased risk of UL in Black Barbadian women. The investigation comprised 37 women clinically diagnosed with UL and 52 controls. The CYP1B1 Leu432Val polymorphism (Leu/Val) was analyzed using the polymerase chain reaction–restriction fragment length polymorphism method. The homozygous Valine432 variant (Val/Val) was predominant in both cases and controls for this population (89 and 83 %, respectively). The odds ratio for risk of developing the disease was 1.33, but this was not statistically significant. We discuss a possible protective function for CYP1B1 based on the high prevalence of this mutant SNP and its lack of association with UL.
KeywordsUterine leiomyoma CYP1B1 Polymorphism Estrogen Single-nucleotide polymorphism
The authors thank the following medical doctors: Dr Carlos Chase, Dr Delores Lewis, and Dr Tracey Archer of the Queen Elizabeth Hospital Barbados and the Barbados Family Planning Clinic, respectively.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
This work was supported by the University of the West Indies, Cave Hill Campus (Campus Research Awards).
Conflicts of interest
- 14.Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost uterine leiomyomata in the United States. Am J Obstet Gynecol. 2013;206(211):1–9.Google Scholar
- 15.Alleyne AT, Austin S, Williams A. Distribution of CYP17α polymorphism and selected physiochemical factors of uterine leiomyoma in Barbados. Metagene. 2014;2:358–65.Google Scholar
- 23.Amant F, Dorfling CM, de Brabanter J, Vandewalle J, Vergote I, Lindebique BJ, et al. A possible role of the cytochrome P450c17α gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. Acta Obstet Gynecol Scand. 2004;83(3):234–39.PubMedGoogle Scholar
- 32.Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet. 1997;6(4):641–47.CrossRefPubMedGoogle Scholar
- 36.Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, Shinde A, et al. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; estradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics. 2000;10(9):761–66.CrossRefPubMedGoogle Scholar